<?xml version="1.0" encoding="UTF-8"?>
<p>Antimicrobial activities (Minimum inhibitory concentrations; MICs) of the isolated metabolite 
 <bold>170</bold> was determined using a serial dilution assay against 
 <italic>Bacillus subtilis</italic> DSM 10, 
 <italic>Chromobacterium violaceum</italic> DSM 30191, 
 <italic>Escherichia coli</italic> DSM 1116, 
 <italic>Micrococcus luteus</italic> DSM 1790, 
 <italic>Pseudomonas aeruginosa</italic> DSM PA14, 
 <italic>Staphylococcus aureus</italic> DSM 346, and 
 <italic>Mycobacterium smegmatis</italic> DSM ATCC700084. Compound 
 <bold>170</bold> showed moderate antibacterial activity against 
 <italic>Staphylococcus aureus</italic> DSM 346 and 
 <italic>Bacillus subtilis</italic> DSM 10, respectively, with a MIC value of 33.33 μg/mL. Oxytetracyclin was used as positive control with MIC values of 0.2 μg/mL and 4.16 μg/mL against 
 <italic>Staphylococcus aureus</italic> DSM 346 and 
 <italic>Bacillus subtilis</italic> DSM 10, respectively [
 <xref rid="B52-ijms-22-00959" ref-type="bibr">52</xref>].
</p>
